Amplyx Pharmaceuticals Funding: $146M Raised, Series C
Amplyx Pharmaceuticals is based in San Diego. It has raised $146M in total funding. Latest round: Series C. Backed by NEA, RiverVest.
Amplyx Pharmaceuticals funding overview
Amplyx Pharmaceuticals is based in San Diego. Amplyx Pharmaceuticals has raised $146M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2017. The round record for Amplyx Pharmaceuticals runs through 2017; nothing later has been disclosed. Investors on record include NEA, RiverVest. 2 distinct backers are named across the disclosed rounds.
Amplyx Pharmaceuticals at a glance
Total raised
$146M
Latest round
Series C
Latest round date
January 2017
Headquarters
San Diego
Notable investors
NEA, RiverVest
Frequently asked about Amplyx Pharmaceuticals funding
How much has Amplyx Pharmaceuticals raised?
Amplyx Pharmaceuticals has raised $146M in total disclosed funding across the rounds on record.
Who has invested in Amplyx Pharmaceuticals?
NEA, RiverVest are named among the investors backing Amplyx Pharmaceuticals.
What was the latest Amplyx Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in January 2017.
Where is Amplyx Pharmaceuticals based?
Amplyx Pharmaceuticals is based in San Diego.
When did Amplyx Pharmaceuticals last raise?
The last disclosed Amplyx Pharmaceuticals round closed in January 2017 at Series C.
Totals shown for Amplyx Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
